Bibliometric and visual analysis of studies on the correlation between gut microbiota and hepatic encephalopathy

Abstract

Abstract: Objective To analyze the research status, hot spots and frontier trends of the correlation between hepatic encephalopathy and gut microbiota over the past 20 years. Methods English literatures on the correlation between hepatic encephalopathy and gut microbiota were searched from the Web of Science (WOS) core database from January 1, 2004 to December 31, 2023. The bibliometric analysis software VOS viewer was used to analyze the countries, institutions, authors and hot spots and frontier directions in this research field. Results A total of 681 articles were retrieved, and the number of papers published gradually increased, Virginia Commonwealth University was the largest institution contributing to these publications. The United States, China and Italy were the largest countries, Bajaj JS was the highest author, and the《world journal of gastroenterology》was the most published journal in this field. The research focus can be summarized as hepatic encephalopathy, gut microbiota, liver cirrhosis, flora disorders and so on. Conclusion Through visual analysis of the hot spots and emerging trends in the study of the correlation between hepatic encephalopathy and gut microbiota, a more comprehensive reference was provided for the research in this field.

Key words: Hepatic encephalopathy, Gut microbiota, Bibliometrics, Visual analysis

CAO Yan-mei, MA Su-ping, XIAO Zhun. Bibliometric and visual analysis of studies on the correlation between gut microbiota and hepatic encephalopathy[J]. Chinese Hepatolgy, 2025, 30(7): 917-921.

References

[1] Wang Y, Li Y, Lv L, et al. Faecal hsa-miR-7704 inhibits the growth and adhesion of Bifidobacterium longum by suppressing ProB and aggravates hepatic encephalopathy[J]. NPJ Biofilms Microbiomes, 2024, 10:13.
[2] Zhu R, Liu L, Zhang G, et al. The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis[J]. Biosci Rep, 2023, 43(6) :BSR20222524.
[3] Tamnanloo F, Ochoa-Sanchez R, Oliveira M M, et al. Multiple ammonia-induced episodes of hepatic encephalopathy provoke neuronal cell loss in bile-duct ligated rats[J]. JHEP Rep, 2023, 5(12) : 100904.
[4] Bajaj J S, Salzman N, Acharya C, et al. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis[J]. JCI Insight, 2019, 4(24) :e133410.
[5] Shah Y R, Ali H, Tiwari A, et al. Role of fecal microbiota transplant in management of hepatic encephalopathy: current trends and future directions[J]. World J Hepatol, 2024, 16(1): 17-32.
[6] Hassouneh R, Bajaj J S. Gut microbiota modulation and fecal transplantation: an overview on innovative strategies for hepatic encephalopathy treatment[J]. J Clin Med, 2021, 10(2) :330.
[7] Jinato T, Sikaroodi M, Fagan A, et al. Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis[J]. Gut Microbes, 2023, 15(2):2288168.
[8] Saboo K, Shamsaddini A, Iyer M V, et al. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy[J]. J Hepatol, 2021, 74(1): 80-88.
[9] Lu K. Cellular pathogenesis of hepatic encephalopathy: an update[J]. Biomolecules, 2023, 13(2): 396.
[10] Won S-M, Oh K K, Gupta H, et al. The link between gut microbiota and hepatic encephalopathy[J]. Int J Mol Sci, 2022, 23(16): 8999.
[11] Wang MW, Ma WJ, Wang Y, et al. Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota[J]. Front Microbiol, 2023, 14:1091167.
[12] Yu X, Jin Y, Zhou W, et al. Rifaximin modulates the gut microbiota to prevent hepatic encephalopathy in liver cirrhosis without impacting the resistome[J]. Front Cell Infect Microbiol, 2022, 11:761192.
[13] Wang Q, Chen C, Zuo S, et al. Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy[J]. J Transl Med, 2023, 21: 395.
[14] Ahluwalia V, Betrapally N S, Hylemon P B, et al. Impaired gut-liver-brain axis in patients with cirrhosis[J]. Sci Rep, 2016, 6: 26800.
[15] Manzhalii E, Moyseyenko V, Kondratiuk V, et al. Effect of a specific escherichia coli nissle 1917 strain on minimal/mild hepatic encephalopathy treatment[J]. World J Hepatol, 2022, 14(3): 634-646.